Form 4: Omada Health Insider Trades Common Stock

Omada Health's Chief Accounting Officer, Craig Gracey, reported a transaction involving the acquisition of 2,083 shares of common stock under a Rule 10b5-1 trading plan.

Summary

• Craig Gracey, Chief Accounting Officer at Omada Health, Inc., acquired 2,083 shares of common stock on June 24, 2026.
• The acquisition was made under a pre-established Rule 10b5-1 trading plan adopted on March 13, 2026.
• The weighted average price for these shares was $19.01, with individual transactions ranging from $19.00 to $19.03.
• Following this transaction, Gracey beneficially owns 5,025 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. While it involves an insider acquiring shares, it's under a pre-arranged plan, and the quantity is relatively small in the context of overall ownership. It doesn't provide significant new information about the company's performance or strategy.

Positives

• The transaction was executed under a Rule 10b5-1 plan, indicating pre-planned and potentially non-insider-trading-related activity.
• The acquisition of shares by a key executive can be interpreted as a positive signal of confidence in the company's future.

Negatives

• The filing reports a disposal of securities, which could be interpreted negatively by some investors, although it was part of a pre-planned trading strategy.

Risks

• The filing does not explicitly mention any risks. However, any insider selling, even under a 10b5-1 plan, can be perceived as a negative signal by the market.
• The price range of the transactions ($19.00-$19.03) might indicate market volatility or specific trading conditions around the transaction date.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, which solely reports a change in beneficial ownership.

Management Comments

• The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The use of a Rule 10b5-1 plan by Omada Health's Chief Accounting Officer is a common practice to facilitate planned stock sales or purchases while adhering to insider trading regulations.

Stakeholder Impact

• Shareholders: The acquisition by an executive may be seen as a minor positive signal, but the pre-planned nature dilutes its impact. The market will likely not react significantly to this specific transaction.
• Employees: May view executive stock purchases as a sign of confidence, potentially boosting morale.
• Creditors/Suppliers: Unlikely to be directly impacted by this insider transaction.

Next Steps

• The reporting person may continue to execute transactions under the existing Rule 10b5-1 plan.
• The company may provide further updates on insider transactions as they occur.

Key Dates

Keywords

Omada Health, OMDA, Form 4, Insider Trading, Rule 10b5-1, Stock Transaction, Common Stock, Beneficial Ownership, Craig Gracey, Chief Accounting Officer